Jasbir Seehra, CEO: Keros Therapeutics KROS Sell · Filed 02/20

Trade details

Type: Insider sale
Amount: $113,432.55
Shares · price: 7,015 sh · $16.17 a share
Held after: 385,708 sh
Stock: Keros Therapeutics KROS
Person: Jasbir SeehraCEO
Trade date: 26/02/19
Filed: 26/02/20
Days to filing: 1 days

Sold 1.8% of holdings

Share of holding sold: 1.8%

Keros Therapeutics trades, last 26 weeks

What else happened in Keros Therapeutics around then

Filed or reported within 30 days of the trade day · 01/20~03/21

Jasbir Seehra's recent trades

No other trades yet.